16 September 2026 editorial review · Item
Beta Bionics Mint (patch pump): review notes
These notes document the scope actually reviewed, including source-access limits. They are not independent clinical certification or a guarantee that every claim was verified.
Read the item evidence page →Thriving evidence review — 16 September 2026
Record: Beta Bionics Mint (patch pump)
Scope and findings:
- Pump FDA clearance announced 14 September; Q1 2027 commercialization target replaces Q2. Separate 3D Intelligence submission remains pending; no current access or new algorithm efficacy inferred. All contradictory display fields and body replaced.
Primary sources checked:
Limits: The review is restricted to the scopes above. Historical efficacy estimates, editorial scoring and country-specific access were not fully reverified unless expressly stated. A manufacturer or conference report retains that evidence level.